Please Wait.....
Report
Cell Analysis Market By Product (Consumables, Services, Instruments, Software), By Technique (Flow cytometry, Mass Spectrometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others), By Application (Oncology, Immunology, Cardiology, Genetic Disease, Stem Cells, Others), By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Academic and Research Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2023-04-01 I 249 Pages I Allied Market Research
The Cell Analysis Market was valued at $17.1 billion in 2022 and is estimated to reach $42.9billion by 2032, exhibiting a CAGR of 9.5% from 2023 to 2032.Cell analysis is used to observe and study the structure, composition, and behavior of individual cells. It involves the use of various techniques such as microscopy, flow cytometry, spectrophotometry, and immunoassay to obtain information about the health and activity of cells. It can be used to detect and diagnose diseases, monitor the response to treatments, and investigate the mechanisms of cellular functions.
The major factors that drive the growth of the market are the rise in technological advancement in cell analysis and an increase in the prevalence of chronic diseases such as cancer and genetic disorders. For instance, according to World Health Organization, cancer is a leading cause of death worldwide, which accounted for nearly 10 million deaths in 2020. Breast cancer accounted for the highest number of cases in 2020, with 2.26 million cases, followed by lung cancer with 2.21 million cases. The most common causes of cancer death in 2020 were lung cancer with 1.80 million deaths followed by colon and rectum cancer with 916,000 cases. In addition, the surge in R&D activities in the pharmaceutical & biotechnology industry and rise in focus on personalized medicines further propel the market growth. However, high cost of cell analysis products and the dearth of skilled professionals are anticipated to hamper the market growth in the upcoming years. Conversely, the high growth potential of single-cell sequencing is expected to provide numerous opportunities for market growth during the forecast period.
The cell analysis market is segmented into product, application, technique, end user, and region. By product, the market is bifurcated into consumables, software, services, and instruments. By application, it is segregated into oncology, immunology, cardiology, stem cell, genetic disease, and others. By technique, the market is categorized into flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), mass spectrometry, and others. On the basis of end-user, it is divided into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Becton, Dickinson and Company, Danaher Corporation, QIAGEN N.V., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Sartorius AG, Biomerieux SA, and Standard BioTools Inc. Key players operating in the market have adopted product launch, product approval, and collaboration as their key strategies to expand their corporate training market share.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell analysis market analysis from 2022 to 2032 to identify the prevailing cell analysis market opportunities.
-Market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
-An in-depth analysis of the cell analysis market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global cell analysis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Technique
- Flow cytometry
- Mass Spectrometry
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Others
By Application
- Oncology
- Immunology
- Cardiology
- Genetic Disease
- Stem Cells
- Others
By Product
- Consumables
- Services
- Instruments
- Software
By End User
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Academic and Research Laboratories
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- South Korea
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- Biomerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Illumina, Inc.
- Qiagen N.V.
- Sartorius AG
- Standard BioTools Inc.
- Thermo Fisher Scientific, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic disease
3.4.1.2. Advancement in cell analysis technology
3.4.1.3. Surge in popularity of personalized medicine approach
3.4.2. Restraints
3.4.2.1. High cost of single cell analysis
3.4.3. Opportunities
3.4.3.1. High growth potential of Single cell sequencing
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: CELL ANALYSIS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Instruments
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Software
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: CELL ANALYSIS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Flow cytometry
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Mass Spectrometry
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Next Generation Sequencing (NGS)
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Polymerase Chain Reaction (PCR)
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: CELL ANALYSIS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Oncology
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Immunology
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Cardiology
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Genetic Disease
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Stem Cells
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Others
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
CHAPTER 7: CELL ANALYSIS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Biotechnology and Pharmaceutical Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Hospitals and Diagnostic Laboratories
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Laboratories
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: CELL ANALYSIS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Technique
8.2.6.1.4. Market size and forecast, by Application
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Technique
8.2.6.2.4. Market size and forecast, by Application
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Technique
8.2.6.3.4. Market size and forecast, by Application
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Technique
8.3.6.1.4. Market size and forecast, by Application
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Technique
8.3.6.2.4. Market size and forecast, by Application
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Technique
8.3.6.3.4. Market size and forecast, by Application
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Technique
8.3.6.4.4. Market size and forecast, by Application
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Technique
8.3.6.5.4. Market size and forecast, by Application
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Technique
8.3.6.6.4. Market size and forecast, by Application
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Technique
8.4.6.1.4. Market size and forecast, by Application
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Technique
8.4.6.2.4. Market size and forecast, by Application
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Technique
8.4.6.3.4. Market size and forecast, by Application
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. South Korea
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Technique
8.4.6.4.4. Market size and forecast, by Application
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. India
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Technique
8.4.6.5.4. Market size and forecast, by Application
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Technique
8.4.6.6.4. Market size and forecast, by Application
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Technique
8.5.6.1.4. Market size and forecast, by Application
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Technique
8.5.6.2.4. Market size and forecast, by Application
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Technique
8.5.6.3.4. Market size and forecast, by Application
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Technique
8.5.6.4.4. Market size and forecast, by Application
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Agilent Technologies, Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Becton, Dickinson and Company
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Biomerieux SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Danaher Corporation
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Sartorius AG
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Illumina, Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. Thermo Fisher Scientific, Inc.
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.9. Qiagen N.V.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. Standard BioTools Inc.
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GLOBAL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CELL ANALYSIS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. CELL ANALYSIS MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 07. CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY REGION, 2022-2032 ($MILLION)
TABLE 10. CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2022-2032 ($MILLION)
TABLE 11. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. CELL ANALYSIS MARKET FOR ONCOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 15. CELL ANALYSIS MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 16. CELL ANALYSIS MARKET FOR GENETIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 17. CELL ANALYSIS MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 18. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 19. GLOBAL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 21. CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 22. CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 23. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 24. CELL ANALYSIS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. NORTH AMERICA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. U.S. CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. U.S. CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 32. U.S. CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. U.S. CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. CANADA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. CANADA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 36. CANADA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. CANADA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. MEXICO CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 39. MEXICO CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 40. MEXICO CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. MEXICO CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 44. EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. EUROPE CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 47. GERMANY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 48. GERMANY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 49. GERMANY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. GERMANY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. FRANCE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. FRANCE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 53. FRANCE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. FRANCE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. UK CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. UK CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 57. UK CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. UK CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. ITALY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. ITALY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 61. ITALY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. ITALY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. SPAIN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 64. SPAIN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 65. SPAIN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SPAIN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. REST OF EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 69. REST OF EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 73. ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 75. ASIA-PACIFIC CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 76. JAPAN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 77. JAPAN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 78. JAPAN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. JAPAN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. CHINA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. CHINA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 82. CHINA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. CHINA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 84. AUSTRALIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 85. AUSTRALIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 86. AUSTRALIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. AUSTRALIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 88. SOUTH KOREA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 89. SOUTH KOREA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 90. SOUTH KOREA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 91. SOUTH KOREA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. INDIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 93. INDIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 94. INDIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 95. INDIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 98. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 99. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 100. LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 101. LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 102. LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 103. LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. LAMEA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 105. BRAZIL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 106. BRAZIL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 107. BRAZIL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 108. BRAZIL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 109. SAUDI ARABIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 110. SAUDI ARABIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 111. SAUDI ARABIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 112. SAUDI ARABIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 113. SOUTH AFRICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 114. SOUTH AFRICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 115. SOUTH AFRICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 116. SOUTH AFRICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 117. REST OF LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 118. REST OF LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 119. REST OF LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 120. REST OF LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 121. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 122. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 123. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 124. AGILENT TECHNOLOGIES, INC.: SERVICE SEGMENTS
TABLE 125. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 126. AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 127. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 128. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 129. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 130. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 131. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 132. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 133. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 134. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 135. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 136. BIOMERIEUX SA: KEY STRATERGIES
TABLE 137. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
TABLE 138. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 139. BIO-RAD LABORATORIES, INC.: PRODUCT SEGMENTS
TABLE 140. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
TABLE 141. BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
TABLE 142. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 143. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 144. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 145. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 146. DANAHER CORPORATION: KEY STRATERGIES
TABLE 147. SARTORIUS AG: KEY EXECUTIVES
TABLE 148. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 149. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 150. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 151. SARTORIUS AG: KEY STRATERGIES
TABLE 152. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 153. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 154. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 155. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 156. ILLUMINA, INC.: KEY STRATERGIES
TABLE 157. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 158. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 159. THERMO FISHER SCIENTIFIC, INC.: SERVICE SEGMENTS
TABLE 160. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 161. QIAGEN N.V.: KEY EXECUTIVES
TABLE 162. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 163. QIAGEN N.V.: PRODUCT SEGMENTS
TABLE 164. QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 165. QIAGEN N.V.: KEY STRATERGIES
TABLE 166. STANDARD BIOTOOLS INC.: KEY EXECUTIVES
TABLE 167. STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT
TABLE 168. STANDARD BIOTOOLS INC.: PRODUCT SEGMENTS
TABLE 169. STANDARD BIOTOOLS INC.: PRODUCT PORTFOLIO
TABLE 170. STANDARD BIOTOOLS INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. CELL ANALYSIS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF CELL ANALYSIS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN CELL ANALYSIS MARKET (2023-2032)
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCELL ANALYSIS MARKET
FIGURE 10. CELL ANALYSIS MARKET, BY PRODUCT, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. CELL ANALYSIS MARKET, BY TECHNIQUE, 2022(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. CELL ANALYSIS MARKET, BY APPLICATION, 2022(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR ONCOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR CARDIOLOGY, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR GENETIC DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR STEM CELLS, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. CELL ANALYSIS MARKET, BY END USER, 2022(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 32. COMPARATIVE SHARE ANALYSIS OF CELL ANALYSIS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 33. CELL ANALYSIS MARKET BY REGION, 2022
FIGURE 34. U.S. CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 35. CANADA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 36. MEXICO CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 37. GERMANY CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 38. FRANCE CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 39. UK CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 40. ITALY CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 41. SPAIN CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF EUROPE CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 43. JAPAN CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 44. CHINA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 45. AUSTRALIA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 46. SOUTH KOREA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 47. INDIA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 48. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 49. BRAZIL CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 50. SAUDI ARABIA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 51. SOUTH AFRICA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 52. REST OF LAMEA CELL ANALYSIS MARKET, 2022-2032 ($MILLION)
FIGURE 53. TOP WINNING STRATEGIES, BY YEAR
FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 56. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 57. COMPETITIVE DASHBOARD
FIGURE 58. COMPETITIVE HEATMAP: CELL ANALYSIS MARKET
FIGURE 59. TOP PLAYER POSITIONING, 2022
FIGURE 60. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 61. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 62. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 65. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 66. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 67. BIOMERIEUX SA: NET SALES, 2019-2021 ($MILLION)
FIGURE 68. BIOMERIEUX SA: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 69. BIOMERIEUX SA: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. BIO-RAD LABORATORIES, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 71. BIO-RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 72. BIO-RAD LABORATORIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 73. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 74. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 75. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 76. SARTORIUS AG: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 77. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 78. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 79. ILLUMINA, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 80. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 81. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 82. THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2019-2021 ($MILLION)
FIGURE 83. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 84. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 85. QIAGEN N.V.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 86. QIAGEN N.V.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 87. STANDARD BIOTOOLS INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 88. STANDARD BIOTOOLS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 89. STANDARD BIOTOOLS INC.: REVENUE SHARE BY REGION, 2022 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security